GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TMS Co Ltd (TSE:4891) » Definitions » ROCE %

TMS Co (TSE:4891) ROCE % : -27.10% (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is TMS Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TMS Co's annualized ROCE % for the quarter that ended in Nov. 2023 was -27.10%.


TMS Co ROCE % Historical Data

The historical data trend for TMS Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TMS Co ROCE % Chart

TMS Co Annual Data
Trend Feb21 Feb22 Feb23
ROCE %
-64.00 63.42 -16.86

TMS Co Quarterly Data
Feb21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
ROCE % Get a 7-Day Free Trial -19.85 -11.42 -16.68 -22.28 -27.10

TMS Co ROCE % Calculation

TMS Co's annualized ROCE % for the fiscal year that ended in Feb. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Feb. 2023 )  (A: Feb. 2022 )(A: Feb. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Feb. 2023 )  (A: Feb. 2022 )(A: Feb. 2023 )
=-520.149/( ( (2739.781 - 285.284) + (3790.215 - 76.161) )/ 2 )
=-520.149/( (2454.497+3714.054)/ 2 )
=-520.149/3084.2755
=-16.86 %

TMS Co's ROCE % of for the quarter that ended in Nov. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Nov. 2023 )  (Q: Aug. 2023 )(Q: Nov. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Nov. 2023 )  (Q: Aug. 2023 )(Q: Nov. 2023 )
=-885.592/( ( (3437.597 - 61.238) + (3229.837 - 69.769) )/ 2 )
=-885.592/( ( 3376.359 + 3160.068 )/ 2 )
=-885.592/3268.2135
=-27.10 %

(1) Note: The EBIT data used here is four times the quarterly (Nov. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TMS Co  (TSE:4891) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


TMS Co ROCE % Related Terms

Thank you for viewing the detailed overview of TMS Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


TMS Co (TSE:4891) Business Description

Traded in Other Exchanges
N/A
Address
1-9 Fuchu-cho, Fuchu-shi, Keio Fuchu 1-chome building 11th floor, Tokyo, JPN, 183-0055
TMS Co Ltd is engaged in the research and development of pharmaceuticals, quasi-drugs, pharmaceutical raw materials, medical equipment and medical consumables.

TMS Co (TSE:4891) Headlines

No Headlines